Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men's Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance]).
Eur Urol Focus. 2022 Nov;8(6):1607-1616. doi: 10.1016/j.euf.2022.03.007. Epub 2022 Apr 30.
Eur Urol Focus. 2022.
PMID: 35504836
Free PMC article.
Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421.
Sonpavde G, Pond GR, Plets M, Tangen CM, Hussain MHA, Lara PN Jr, Goldkorn A, Garzotto MG, Mack PC, Higano CS, Vogelzang NJ, Thompson IM Jr, Twardowski PW, Van Veldhuizen PJ Jr, Agarwal N, Carducci MA, Monk JP, Quinn DI.
Sonpavde G, et al. Among authors: van veldhuizen pj jr.
Clin Genitourin Cancer. 2017 Dec;15(6):635-641. doi: 10.1016/j.clgc.2017.05.014. Epub 2017 May 10.
Clin Genitourin Cancer. 2017.
PMID: 28579151
Free PMC article.
Item in Clipboard
Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032.
Smith DC, Tangen CM, Van Veldhuizen PJ Jr, Harrer GW, Golshayan A, Mills GM, Vogelzang NJ, Thompson IM, Hussain MH.
Smith DC, et al. Among authors: van veldhuizen pj jr.
Urology. 2011 May;77(5):1172-6. doi: 10.1016/j.urology.2010.12.043. Epub 2011 Feb 21.
Urology. 2011.
PMID: 21334731
Free PMC article.
Clinical Trial.
Item in Clipboard
Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer.
Dorff TB, Goldman B, Pinski JK, Mack PC, Lara PN Jr, Van Veldhuizen PJ Jr, Quinn DI, Vogelzang NJ, Thompson IM Jr, Hussain MH.
Dorff TB, et al. Among authors: van veldhuizen pj jr.
Clin Cancer Res. 2010 Jun 1;16(11):3028-34. doi: 10.1158/1078-0432.CCR-09-3122. Epub 2010 May 18.
Clin Cancer Res. 2010.
PMID: 20484019
Free PMC article.
Clinical Trial.
Item in Clipboard
Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urothelium.
Petrylak DP, Tangen CM, Van Veldhuizen PJ Jr, Goodwin JW, Twardowski PW, Atkins JN, Kakhil SR, Lange MK, Mansukhani M, Crawford ED.
Petrylak DP, et al. Among authors: van veldhuizen pj jr.
BJU Int. 2010 Feb;105(3):317-21. doi: 10.1111/j.1464-410X.2009.08799.x. Epub 2009 Nov 2.
BJU Int. 2010.
PMID: 19888985
Clinical Trial.
Item in Clipboard
S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach.
Blanke CD, Chansky K, Christman KL, Hundahl SA, Issell BF, Van Veldhuizen PJ Jr, Budd GT, Abbruzzese JL, Macdonald JS.
Blanke CD, et al. Among authors: van veldhuizen pj jr.
Am J Clin Oncol. 2010 Apr;33(2):117-20. doi: 10.1097/COC.0b013e318199fb84.
Am J Clin Oncol. 2010.
PMID: 19770625
Free PMC article.
Clinical Trial.
Item in Clipboard
Southwest Oncology Group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes.
Beer TM, Goldman B, Synold TW, Ryan CW, Vasist LS, Van Veldhuizen PJ Jr, Dakhil SR, Lara PN Jr, Drelichman A, Hussain MH, Crawford ED.
Beer TM, et al. Among authors: van veldhuizen pj jr.
Clin Genitourin Cancer. 2008 Sep;6(2):103-9. doi: 10.3816/CGC.2008.n.016.
Clin Genitourin Cancer. 2008.
PMID: 18824433
Clinical Trial.
Item in Clipboard
Cite
Cite